$1.23
-0.03-2.38%
At close: -
$1.31
0.086.50%
After Hours: 7:00 AM EDT
Bone Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bone Biologics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-2.37 | $-0.60 | -295.0 % |
Jun 2024 | 2024-08-09 | $-0.67 | $-1.39 | 51.8 % |
Mar 2024 | 2024-05-14 | $-1.31 | $-7.60 | 82.8 % |
Dec 2023 | 2024-02-21 | $-29.33 | $-7.60 | -285.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Bone Biologics (BBLG) is scheduled to report earnings on February 19, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-2.37, which missed the estimate of $-0.60.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.